ARGSQ Projected Dividend Yield
Argos Therapeutics Inc ( OTCBB : ARGSQ )Argos Therapeutics is an immuno-oncology company focused on the development and commercialization of individualized immunotherapies for the treatment of cancer based on Co.'s proprietary precision immunotherapy technology platform called Arcelis. Co.'s proprietary Arcelis precision immunotherapy technology platform utilizes biological components from a patient's own cancer cells or virus to generate individualized immunotherapies. Co.'s primary product candidate is rocapuldencel-T, which is for the treatment of metastatic renal cell carcinoma and other cancers. Co. is also developing AGS-004, a second Arcelis-based product candidate for the treatment of Human Immunodeficiency Virus. 20 YEAR PERFORMANCE RESULTS |
ARGSQ Dividend History Detail ARGSQ Dividend News ARGSQ Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |